Advarra

Advarra is a premier provider of institutional review board (IRB), institutional biosafety committee (IBC), and other research compliance services in North America. Advarra leverages its strengths in technology, regulatory expertise, and customer service to serve the increasingly complex needs associated with research. In November 2017, Chesapeake IRB and Schulman IRB merged to create Advarra. Linden is an investment adviser registered with the United States Securities and Exchange Commission. Linden may only transact business or render personalized investment advice in those states and international jurisdictions where it is registered, has notice filed or is otherwise excluded or exempted from registration requirements. The purpose of this web site is for information distribution on products and services. Any communications with prospective clients residing in states or international jurisdictions where Linden is not registered or licensed shall be limited so as not to trigger registration of licensing requirements. Nothing on this website is to be construed as a solicitation to offer investment advice or services. Information about investing in Linden’s funds is only available in the form of Private Placement Memorandum and other offering documents. These documents contain information to help investors evaluate Linden’s funds’ investment objectives, risks, charges and expenses, among other factors, before considering an investment. © 2021 Linden LLC. All rights reserved.